Concepedia

Ilona Kariv

IK

30

Publications

2.4K

Citations

19

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Wilmington University

DuPont (United States)

Quantitative BioSciences

Bristol-Myers Squibb (United States)

Ilona Kariv is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1992–2022

30

Publications

30

Microfluidic sorting of mammalian cells by optical force switching

Mark M. Wang, Eugene Tu, Daniel E. Raymond et al. · Nature Biotechnology · 2004 · 687 citations

, , +8

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

, , +19

Development of a High Throughput Equilibrium Dialysis Method

Ilona Kariv, Hong Cao, Kevin R. Oldenburg · Journal of Pharmaceutical Sciences · 2001 · 150 citations

, , +6

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 122 citations · Full text

, , +17

A multiplexed microfluidic system for evaluation of dynamics of immune–tumor interactions

Nathan W. Moore, Daniel Doty, Mark Zielstorff et al. · Lab on a Chip · 2018 · 99 citations

, , +21

Rows per page

1–5 of 30